Clin Lung Cancer.2020 May;S1525-7304(20)30155-8. doi: 10.1016/j.cllc.2020.05.015.Epub 2020-05-23.
MET増幅を有するEGFR変異肺腺がんにおけるEGFRおよびMET阻害とクリゾチニブの併用。A Brief Report
Combining EGFR and MET Inhibition With Crizotinib in EGFR-mutated Lung Adenocarcinoma Harboring MET Amplification: A Brief Report.
- Marjorie Aubanel
- Aurélie Swalduz
- Virginie Avrillon
- Louis Doublet
- Bénédicte Mastroianni
- Eve-Marie Neidhardt-Bérard
- Maurice Pérol
PMID: 32620469 DOI: 10.1016/j.cllc.2020.05.015.
抄録
抄録はありません
